| Sep 3 |
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
|
| Sep 3 |
Sector Update: Health Care Stocks Decline Late Afternoon
|
| Sep 3 |
Heard on the Street: Pfizer Better Watch Out for This Biotech
|
| Sep 3 |
Biotech Startup Vaxcyte Is a Threat to Pfizer and Merck. A Vaccine Candidate Is Why.
|
| Sep 3 |
Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive Market
|
| Sep 3 |
Biggest stock movers today: U, BA, X, and more
|
| Sep 3 |
Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
|
| Sep 3 |
Vaxcyte's shares hit record high on early data on pneumococcal vaccine
|
| Sep 3 |
Vaxcyte pneumococcal shot matches Pfizer’s in early trial for safety
|
| Sep 3 |
Vaxcyte’s “best-case” data for pneumococcal vaccine boost shares
|
